Study exonerates Ozempic and Wegovy for causing suicidal thoughts
A new study from Case Western University in the US has cleared the diabetes drug and weight loss medication semaglutide, which is included in the products Ozempic and Wegovy, of increasing the risk of suicidal thoughts, Danish business daily Børsen reports.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
FDA will not act on European study of GLP-1 drugs
For subscribers